Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Menzies

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Communicable Diseases Intelligence Quarterly Report|March 23, 2010
Annual report: surveillance of adverse events following immunisation in Australia, 2008Rob Menzies, Deepika Mahajan, Michael S Gold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014Sanjay Jayasinghe, Rob Menzies, Clayton Chiu, et al.
Vaccine|November 1, 2015
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous childrenSanjay Jayasinghe, Clayton Chiu, Rob Menzies, et al.
Vaccine|February 24, 2021
Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkageAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|September 15, 2007
Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, AustraliaRob Menzies, Peter McIntyre, Ray Reid, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Communicable Diseases Intelligence Quarterly Report|March 23, 2010
Annual report: surveillance of adverse events following immunisation in Australia, 2008Rob Menzies, Deepika Mahajan, Michael S Gold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014Sanjay Jayasinghe, Rob Menzies, Clayton Chiu, et al.
Vaccine|November 1, 2015
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous childrenSanjay Jayasinghe, Clayton Chiu, Rob Menzies, et al.
Vaccine|February 24, 2021
Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkageAlamgir Kabir, Anthony T Newall, Deborah Randall, et al.
Vaccine|September 15, 2007
Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, AustraliaRob Menzies, Peter McIntyre, Ray Reid, et al.
Pageof 2